CLINICAL_TRIALS
trial_result
· 2013-03-21
Clinical Trial Update: Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia
Summary
Phase IV trial update for GRALISE (gabapentin) in postherpetic neuralgia; the study completed and results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Depomed | Conditions: Post Herpetic Neuralgia | Status: COMPLETED | Results posted: 2013-03-21